Keyphrases
Psoriatic
100%
Psoriasis
100%
Kinase Activation
100%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
100%
Dermatitis
100%
Interleukin-17 (IL-17)
37%
Anisomycin
37%
BIRB-796
37%
Therapeutic Target
25%
Transcriptome Analysis
25%
Topical Therapy
25%
Topical Treatment
25%
Murine Skin
25%
Psoriatic Skin
25%
Skin Specimen
25%
Inflammation
12%
Immune Response
12%
Small Molecule Inhibitors
12%
Gene Expression
12%
Recombinant
12%
Interleukin-1β
12%
Small Molecules
12%
Neutrophil Infiltration
12%
Chronic Inflammatory Skin Disease
12%
Epidermis
12%
Reduced Expression
12%
Human Keratinocytes (HaCaT)
12%
P38 Activation
12%
CXCL1
12%
Epidermal Thickening
12%
IL-24
12%
Skin Response
12%
Imiquimod-induced
12%
Biochemistry, Genetics and Molecular Biology
Anisomycin
100%
P38 Mitogen-Activated Protein Kinases
100%
Small Molecule
66%
Gene Expression Profiling
66%
Animal Model
33%
Gene Expression
33%
Murine
33%
Immune Response
33%
Neutrophil Chemotaxis
33%
Keratinocyte
33%
Interleukin 17
33%
Medicine and Dentistry
Psoriasis
100%
Dermatitis
100%
Mitogen Activated Protein Kinase P38
100%
Anisomycin
27%
Gene Expression Profiling
18%
Topical Treatment
18%
Ex Vivo
18%
In Vitro
9%
Immune Response
9%
Gene Expression
9%
Keratinocyte
9%
Interleukin 17
9%
Neutrophil Chemotaxis
9%
Imiquimod
9%
Immunology and Microbiology
Dermatitis
100%
Mitogen
100%
Gene Expression Assay
50%
Immune Response
25%
Gene Expression
25%
Murine
25%
Neutrophil Chemotaxis
25%
Imiquimod
25%
Keratinocyte
25%
Interleukin 17
25%
Pharmacology, Toxicology and Pharmaceutical Science
Psoriasis
100%
Dermatitis
100%
Mitogen Activated Protein Kinase P38
100%
Anisomycin
27%
Inflammation
9%
Murine
9%
Interleukin 17
9%
Imiquimod
9%